| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |